Inhibition of RUNX1 using the chemical inhibitor Ro5-3335 (Cunningham et al., 2012) in MLL-AF9 leukemia cells causes cell number depletion or cell cycle arrest and suppressed leukemia development (Goyama et al., 2013). Here, KMT2A is linked to leukemia.